Delivery Order SPE2DE24D0013-SPE2D625F3VJS
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $2,471.70 by the Defense Department's Medical Supply Chain organization on July 18, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order carries no set-aside designation and represents procurement of diagnostic equipment, reagents, or testing services from Cepheid's core product portfolio, which includes GeneXpert...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $6,468.30 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of August 18, 2025, covers diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The award carries no set-aside designation and represents a task order under...
- The Defense Logistics Agency awarded a $40.8K delivery order (Contract 4569470191) to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, for the supply of COVID-19/Flu/RSV testing solutions. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, carries no set-aside designation and represents part of Cepheid's broader supply relationship with the Defense Department's medical supply chain operations. Cepheid specializes in...
- The Defense Logistics Agency has awarded a $13.6K delivery order (XPRS4PLEX-10) to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, awarded on September 11, 2025, with an ultimate completion date of September 18, 2025, represents a continuation of the federal government's procurement of Cepheid's diagnostic testing capabilities. The award carries no set-aside designation and will be performed at Cepheid's...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, received a $6,800 firm fixed-price delivery order (XPRS4PLEX-10) from the Defense Department's Medical Supply Chain on August 22, 2025, with an ultimate completion date of August 29, 2025. This delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of molecular diagnostic technologies and test kits to federal defense and healthcare systems. This...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $1,800 firm fixed-price delivery order to Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California. This delivery order, issued on August 25, 2025, with an ultimate completion date of September 2, 2025, carries no set-aside designation and represents a continuation of the agency's procurement of advanced diagnostic solutions. The work will be performed at Cepheid's Sunnyvale facility....
- The U.S. Defense Logistics Agency awarded a $6,674.40 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on September 16, 2025. This delivery order, with a completion date of September 23, 2025, represents a non-set-aside award for diagnostic equipment or testing solutions that will be performed at Cepheid's Sunnyvale facility. Cepheid specializes in advanced diagnostic systems and test kits for infectious diseases and...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $1,840 on August 11, 2025, by the Defense Department's Medical Supply Chain agency. This firm fixed-price contract, designated as XPRSTREPA-10, is set to conclude by August 18, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract represents a discrete delivery order under Cepheid's existing federal contracting relationships, through which the...
- The U.S. Defense Department's Medical Supply Chain awarded a $27,235.80 firm fixed-price delivery order to Cepheid Inc. on June 6, 2025, with an ultimate completion date of June 13, 2025. This delivery order, issued under contract number XPRSMVP-10, carries no set-aside designation and represents work to be performed at Cepheid's headquarters in Sunnyvale, California. Cepheid is a leading manufacturer of molecular diagnostic solutions, specializing in advanced GeneXpert diagnostic systems and...
- The U.S. Defense Department's Medical Supply Chain awarded a $1,437.57 firm fixed-price delivery order to Cepheid Inc. on September 15, 2025, with an ultimate completion date of September 22, 2025. The contract, identified as GXCT/NG-10, carries no set-aside designation and is being performed in Sunnyvale, California, where Cepheid maintains its headquarters. This delivery order represents a continuation of the Department's procurement of molecular diagnostic solutions from Cepheid, a for-profit...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F3VJSDelivery Order
The Defense Logistics Agency awarded a $6,420 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, with a completion date of October 2, 2025. This delivery order, issued under contract number GXMRSA-NXG-10, carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of diagnostic equipment and testing services to the Department of Defense supply chain. Cepheid specializes in advanced molecular diagnostic systems, including its GeneXpert platform, which delivers rapid detection and identification capabilities for infectious diseases including COVID-19, influenza, respiratory syncytial virus, and other clinical conditions requiring microbiology testing. Cepheid maintains established relationships with multiple federal agencies through several significant indefinite delivery vehicles, including a single-award IDV with the Veterans Integrated Service Network 6 valued at $32.8 million through September 2030 and a second IDV with Veterans Integrated Service Network 21 valued at $2.5 million focused on polymerase chain reaction testing for laboratory microbiology. The current delivery order aligns with Cepheid's primary federal contracting focus of supplying molecular diagnostic testing reagents, assays, and equipment maintenance services across the defense and veterans healthcare sectors. As a for-profit entity with consistent federal contracting experience and specialized expertise in infectious disease diagnostics, Cepheid continues to serve as a key supplier for the federal government's diagnostic testing requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 9/18/25 |